Alcon announced that its merger with Novartis has closed, enhancing the world’s leading eye care business by uniting the strengths of Alcon, CIBA Vision and Novartis. The newly formed Alcon business becomes the second largest division of Novartis, leveraging its collective eye care product portfolio and expertise to accelerate growth and product innovation. The division will be headquartered in Fort Worth, Texas, with operations in 75countries.
Alcon’s leadership in eye care is founded in pharmaceutical, surgical, and over-the-counter ophthalmic products including contact lens care, with differentiated technology, created through dedicated research and development. With the integration of CIBA Vision into Alcon, the company now offers the widest spectrum of contact lenses and lens care brands. Read the rest of this entry ?
